What Legal Duty Do Practitioners Have to Warn Potential Victims of a Patient?
Two years after her husband was killed, Mr Z’s grandmother sued several of the hospital’s physicians.
Mood Disorders
Caplyta Approved for Bipolar Depression in Adults
The approval was supported by data from two phase 3 studies that evaluated Caplyta as monotherapy and adjunctive therapy with lithium or valproate in adults with bipolar depression.
Negative Allosteric Modulator Gets Fast Track Status for Social Anxiety Disorder
The Company will evaluate BNC210 in patients with SAD in the phase 2 PREVAIL trial.
SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19
Relative risks for mortality significantly reduced for any SSRI, fluoxetine, and fluoxetine or fluvoxamine
Psychedelic Drug Shows Promise in Treatment-Resistant Depression
Currently, psilocybin, a serotonin receptor agonist, is classified as a Schedule I drug in the US.
Cariprazine Promising as Adjunctive Treatment for Major Depressive Disorder
The Company intends to submit a supplemental New Drug Application to the FDA for cariprazine for the adjunctive treatment of major depressive disorder.
Lybalvi Now Available for Schizophrenia, Bipolar I Disorder
Lybalvi is an atypical antipsychotic comprised of samidorphan co-formulated with olanzapine in a single bilayer tablet.
Transcranial Magnetic Stimulation Device Cleared for Anxious Depression
The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.
Lyme Disease Tied to Higher Risk for Psychiatric Conditions, Suicide
Risk particularly heightened in the six months following diagnosis
Exposure to Prenatal Antipsychotics Seems Safe
No increased risk seen for ADHD, ASD, small for gestational age with prenatal antipsychotics exposure
